id,patient.id,regime,treatment_date,drug.id,drug.manufacturer,drug.therapy_class
27,160,-,05-May-2019,beclabuvir,BMS,NS5B non-nucleotide polymerase inhibitor
28,161,-,08-Sep-2020,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor
29,163,1 tablet per day,07-Jan-2011,ombitasvir,AbbVie,NS5B nucleotide polymerase inhibitor
31,160,2 tablets per day,07-Jan-2011,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor
32,161,1 tablet per day,05-May-2019,dasabuvir,-,-
33,161,1 tablet per day,05-May-2019,ledipasvir,Gilead,NS5A inhibitor
34,180,-,08-Sep-2020,ombitasvir,AbbVie,NS5B nucleotide polymerase inhibitor
35,187,-,07-Jan-2011,paritaprevir,AbbVie,NS3A/4A protease inhibitor
36,189,-,05-Feb-1988,ritonavir,AbbVie,NS5A inhibitor
57,188,-,05-Jun-2019,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor
58,188,-,05-Jul-2019,ombitasvir,AbbVie,NS5B nucleotide polymerase inhibitor
59,188,2 tablets per day,08-Aug-2020,dasabuvir,-,-
60,190,1 tablet per day,30-Jun-2011,simeprevir,Janssen,NS3A/4A protease inhibitor
61,194,2 tablets per day,30-Jun-2011,ledipasvir,Gilead,NS5A inhibitor
